Resources

Skin ModelsNativeSkin®, an immunocompetent human skin model to study antigen uptake and processing by Langerhans cells Research by E. Pagès1, L. Mondoulet3, E. Bonnefont1, E. Braun1, V. Dhelft2, C. Dupont3, H. Sampson2, P. Descargues1 1Genoskin, 2DBV Technologies, 3Hôpital Necker, Université Paris-Descartes Scientific Context Epicutaneous immunotherapy (EPIT) using Viaskin® patches has been shown to induce tolerance in sensitized mice (Dioszeghy, ClinRead more

Skin ModelsCBD in Skin Care: Impacts of Time & Tissue Model Research by A. Langerveld1, E. Lehigh1, S. Wheeler1, T. McCraw2, E. Coryell2, P. Descargues3, C. Belles3 1Genemarkers, 2Skin Science Advisors, 3Genoskin About this Research CBD has been hailed as the hottest new ingredient in skin care, with CBD-containing products appearing on the market at a record pace over theRead more

HypoSkin®Accelerate Your ResearchHypoSkin®: Live & Biostabilized Human Skin Models HypoSkin® human skin models currently offer the closest alternative to directly injecting a compound in an actual person’s skin. HypoSkin® offers a complete ecosystem of immune and structural human skin cells. Thanks to a patented technology, we ensure that every model is standardized for reproducible results and suitable for shipment worldwide.Read more

Scientific posterEvaluation of local inflammatory reactions following subcutaneous injection of a pro-inflammatory cocktail in a fully human ex vivo skin model. Poster IID2018.Subcutaneous (SC) injections can evoke local reactions such as inflammation or necrosis. Preclinical development of SC therapies relies on animal models to characterize these responses, however, translation of these models to the clinic is often limited and no singleRead more

Vaccine DevelopmentEvaluation of Vaccine Potency with High-Dimensional Immune Profiling Using an Innovative Bio-stabilized Human Skin Model Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin Scientific Context In the rapidly evolving field ofRead more

Top-level science through the eyes of an expert.The eighth Webinar. The next episode of the Genoskin Webinar series is now scheduled on October 17, 2024 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Manon Scholaert, Scientist at Genoskin. Watch the replayIn thisRead more